Switching from one vaccine product to another can have a significant impact on a country’s budget. For Palestine’s rotavirus vaccination program, a switch paid off.
This brief describes an economic analysis conducted by PATH in partnership with the Rostropovich-Vishnevskaya Foundation and the Palestinian Ministry of Health to assess the economic implications of Palestine’s switch from ROTARIX to ROTAVAC.
Tags
- Planning, budgeting and financing
PORTFOLIO-LESSONS
You can find more information about "PORTFOLIO-LESSONS" in the following Hot Topics:
| Title | Author | Year | Type | Language |
|---|
| The effects of switching from 10 to 5-dose vials of MR vaccine on vaccination coverage and wastage: A mixed-method study in Zambia | Kirstin Krudwig, Barbara Knittel, Ali Karim, Natasha Kanagat, Wendy Prosser, Guissimon Phiri, Frances Mwansa, Robert Steinglass | 2020 | Journal article | English |
| A Switch for Sustainability in Ghana's Rotavirus Vaccine Program | George Armah | 2020 | Case study | English |
| Introducing 5-dose Measles-Rubella Vaccine Vials in Zambia: Research Findings | Dose Per Container Partnership (DPCP), JSI Research & Training Institute, Inc | 2019 | Case study | English |
| The switch from ROTARIX to ROTAVAC in Ghana: Answers to four key questions | PATH | 2022 | Report | English |
| Economic Implications of Switching Rotavirus Vaccine Products in Palestine's Immunization Program | PATH | 2020 | Case study | Russian |
| The Health Benefits of Rotavirus Immunization for Children in Palestine: Results of a Vaccine Impact Analysis | PATH, Rostropovich-Vishnevskaya Foundation, Palestine Ministry of Health | 2021 | Report | Russian |
Added by: Laura Kallen
Added on: 2020-12-17 09:31:04
Hits: 2021
